0001104659-21-117993.txt : 20210921 0001104659-21-117993.hdr.sgml : 20210921 20210921183807 ACCESSION NUMBER: 0001104659-21-117993 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210917 FILED AS OF DATE: 20210921 DATE AS OF CHANGE: 20210921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FFI FUND LTD CENTRAL INDEX KEY: 0001081816 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39802 FILM NUMBER: 211267508 BUSINESS ADDRESS: STREET 1: DMS HOUSE, 20 GENESIS CLOSE STREET 2: GRAND CAYMAN CITY: GEORGE TOWN STATE: E9 ZIP: KY1-1208 BUSINESS PHONE: 345-943-7665 MAIL ADDRESS: STREET 1: DMS HOUSE, 20 GENESIS CLOSE STREET 2: GRAND CAYMAN CITY: GEORGE TOWN STATE: E9 ZIP: KY1-1208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FYI Ltd CENTRAL INDEX KEY: 0001411786 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39802 FILM NUMBER: 211267507 BUSINESS ADDRESS: STREET 1: P.O. BOX 1344, 20 GENESIS CLOSE STREET 2: DMS HOUSE CITY: GRAND CAYMAN, KY1-1108 STATE: e9 ZIP: 00000 BUSINESS PHONE: 3459467665 MAIL ADDRESS: STREET 1: P.O. BOX 1344, 20 GENESIS CLOSE STREET 2: DMS HOUSE CITY: GRAND CAYMAN, KY1-1108 STATE: e9 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bracebridge Capital, LLC CENTRAL INDEX KEY: 0001426486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39802 FILM NUMBER: 211267505 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: SUITE 1500 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-497-3500 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: SUITE 1500 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olifant Fund, Ltd. CENTRAL INDEX KEY: 0001639809 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39802 FILM NUMBER: 211267506 BUSINESS ADDRESS: STREET 1: DMS HOUSE, 20 GENESIS CLOSE STREET 2: GRAND CAYMAN CITY: GEORGE TOWN STATE: E9 ZIP: KY1-1208 BUSINESS PHONE: 345-943-7665 MAIL ADDRESS: STREET 1: DMS HOUSE, 20 GENESIS CLOSE STREET 2: GRAND CAYMAN CITY: GEORGE TOWN STATE: E9 ZIP: KY1-1208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clarus Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001817944 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851231852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 SKOKIE BOULEVARD, SUITE 340 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: (847) 562-4300 MAIL ADDRESS: STREET 1: 555 SKOKIE BOULEVARD, SUITE 340 CITY: NORTHBROOK STATE: IL ZIP: 60062 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Acquisition Corp. DATE OF NAME CHANGE: 20200713 4 1 tm2128142-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-09-17 1 0001817944 Clarus Therapeutics Holdings, Inc. CRXT 0001081816 FFI FUND LTD C/O BRACEBRIDGE CAPITAL, LLC 888 BOYLSTON STREET, 15TH FLOOR BOSTON MA 02199 0 0 1 0 0001411786 FYI Ltd C/O BRACEBRIDGE CAPITAL, LLC 888 BOYLSTON STREET, 15TH FLOOR BOSTON MA 02199 0 0 1 0 0001639809 Olifant Fund, Ltd. C/O BRACEBRIDGE CAPITAL, LLC 888 BOYLSTON STREET, 15TH FLOOR BOSTON MA 02199 0 0 1 0 0001426486 Bracebridge Capital, LLC 888 BOYLSTON STREET, 15TH FLOOR BOSTON MA 02199 0 0 1 0 Common Stock 2021-09-17 4 S 0 127360 9.20 D 2102495 I See footnote Shares of common stock, $0.0001 par value per share ("Shares") of Clarus Therapeutics Holdings, Inc. (the "Issuer"), were sold as follows: (i) 92,973 Shares were sold by FFI Fund Ltd. ("FFI"), (ii) 17,830 Shares were sold by FYI Ltd. ("FYI"), and (iii) 16,557 Shares were sold by Olifant Fund, Ltd. (together with FFI and FYI, the "Bracebridge Funds"). Bracebridge Capital, LLC (the "Investment Manager") is the investment manager of each of the Bracebridge Funds and has the authority to vote and dispose of all the Shares reflected herein. This price is a weighted-average price. These Shares were sold in multiple transactions at prices ranging from $9.05 to $9.34, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the ranges set forth in this explanatory note. Each of the Bracebridge Funds and the Investment Manager disclaims beneficial ownership of the Shares except to the extent of any pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the Shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. /s/ FFI Fund Ltd., By Nancy Zimmerman, Authorized Representative 2021-09-21 /s/ FYI Ltd., By Nancy Zimmerman, Authorized Representative 2021-09-21 /s/ Olifant Fund, Ltd., By Nancy Zimmerman, Authorized Representative 2021-09-21 /s/ Bracebridge Capital, LLC, By Nancy Zimmerman, Authorized Representative 2021-09-21